Pillar 4: GLP-1 receptor agonists and dual agonists GLP-1-based therapies (such as semaglutide and tirzepatide) are a legitimate pillar for insulin resistance management when obesity and/or appetite dysregulation are part of the picture
McGeer PL, Itagaki S, Boyes BE, McGeer EG
As already noted, there are two other modes
When combined with optimised B12 levels, your follicles have both the growth signals and the nutritional support they need
4.5 Musculoskeletal effects T2DM raises the risk of fractures, poor bone repair, and other factors that lead to brittle bones (64)
The weight loss produced by these compounds, even in the most favorable studies, amounts to approximately 2-4 pounds over 8-12 weeks